ADAMTS-13 cysteine-rich/spacer domains are functionally essential for von Willebrand factor cleavage

被引:149
作者
Soejima, K [1 ]
Matsumoto, M
Kokame, K
Yagi, H
Ishizashi, H
Maeda, H
Nozaki, C
Miyata, T
Fujimura, Y
Nakagaki, T
机构
[1] Chemo Sero Therapeut Res Inst, Res Dept 1, Kumamoto 8691298, Japan
[2] Nara Med Univ, Dept Blood Transfus Med, Nara, Japan
[3] Natl Cardiovasc Ctr, Res Inst, Osaka, Japan
[4] Nara Med Univ, Dept Hlth Sci, Nara, Japan
关键词
D O I
10.1182/blood-2003-03-0908
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
A severe lack of von Willebrand factor-cleaving protease (VWF-CP) activity can cause thrombotic thrombocytopenic purpura (TTP). This protease was recently identified as a member of the ADAMTS family, ADAMTS-13. It consists of a pre-proregion, a metalloprotease domain, a disintegrin-like domain, a thrombospondin type-1 motif (Tsp1), a cysteine-rich domain, a spacer domain, additional Tsp1 repeats, and CUB domains. To explore the structural and functional relationships of ADAMTS-13, we prepared here 13 sequential COOH-terminal truncated mutants and a single-point mutant (ArgGlyAsp [RGD] to ArgGlyGlu [RGE] in the cysteine-rich domain) and compared the activity of each mutant with that of the wild-type protein. The results revealed that the truncation of the cysteine-rich/spacer domains caused a remarkable reduction in VWF-CP activity. We also prepared immunoglobulin G (IgG) fractions containing inhibitory auto-antibodies against ADAMTS-13 from plasma from 3 patients with acquired TTP, and we performed mapping of their epitopes using the aforementioned mutants. The major epitopes of these antibodies were found to reside within the cysteine-rich/spacer domains. These results suggest that the ADAMTS-13 cysteine-rich/spacer domains are essential for VWF-CP activity. (C) 2003 by The American Society of Hematology.
引用
收藏
页码:3232 / 3237
页数:6
相关论文
共 40 条
[1]   EPITOPE MAPPING OF THE VONWILLEBRAND-FACTOR SUBUNIT DISTINGUISHES FRAGMENTS PRESENT IN NORMAL AND TYPE-IIA VONWILLEBRAND DISEASE FROM THOSE GENERATED BY PLASMIN [J].
BERKOWITZ, SD ;
DENT, J ;
ROBERTS, J ;
FUJIMURA, Y ;
PLOW, EF ;
TITANI, K ;
RUGGERI, ZM ;
ZIMMERMAN, TS .
JOURNAL OF CLINICAL INVESTIGATION, 1987, 79 (02) :524-531
[2]   Cloning, expression analysis, and structural characterization of seven novel human ADAMTSs, a family of metalloproteinases with disintegrin and thrombospondin-1 domains [J].
Cal, S ;
Obaya, AJ ;
Llamazares, M ;
Garabaya, C ;
Quesada, V ;
López-Otín, C .
GENE, 2002, 283 (1-2) :49-62
[3]   HETEROGENEITY OF PLASMA VONWILLEBRAND-FACTOR MULTIMERS RESULTING FROM PROTEOLYSIS OF THE CONSTITUENT SUBUNIT [J].
DENT, JA ;
GALBUSERA, M ;
RUGGERI, ZM .
JOURNAL OF CLINICAL INVESTIGATION, 1991, 88 (03) :774-782
[4]   IDENTIFICATION OF A CLEAVAGE SITE DIRECTING THE IMMUNOCHEMICAL DETECTION OF MOLECULAR ABNORMALITIES IN TYPE-IIA VONWILLEBRAND-FACTOR [J].
DENT, JA ;
BERKOWITZ, SD ;
WARE, J ;
KASPER, CK ;
RUGGERI, ZM .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1990, 87 (16) :6306-6310
[5]   ADAMTS-13 rapidly cleaves newly secreted ultralarge von Willebrand factor multimers on the endothelial surface under flowing conditions [J].
Dong, JF ;
Moake, JL ;
Nolasco, L ;
Bernardo, A ;
Arceneaux, W ;
Shrimpton, CN ;
Schade, AJ ;
McIntire, LV ;
Fujikawa, K ;
López, JA .
BLOOD, 2002, 100 (12) :4033-4039
[6]   Autocatalytic cleavage of ADAMTS-4 (Aggrecanase-1) reveals multiple glycosaminoglycan-binding sites [J].
Flannery, CR ;
Zeng, WL ;
Corcoran, C ;
Collins-Racie, LA ;
Chockalingam, PS ;
Hebert, T ;
Mackie, SA ;
McDonagh, T ;
Crawford, TK ;
Tomkinson, KN ;
LaVallie, ER ;
Morris, EA .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2002, 277 (45) :42775-42780
[7]   Purification of human von Willebrand factor-cleaving protease and its identification as a new member of the metalloproteinase family [J].
Fujikawa, K ;
Suzuki, H ;
McMullen, B ;
Chung, D .
BLOOD, 2001, 98 (06) :1662-1666
[8]  
FUJIMURA Y, 1994, HAEMOSTASIS THROMBOS, P379
[9]   TRIPLET STRUCTURE OF VON-WILLEBRAND-FACTOR REFLECTS PROTEOLYTIC DEGRADATION OF HIGH-MOLECULAR-WEIGHT MULTIMERS [J].
FURLAN, M ;
ROBLES, R ;
AFFOLTER, D ;
MEYER, D ;
BAILLOD, P ;
LAMMLE, B .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1993, 90 (16) :7503-7507
[10]   Deficient activity of von Willebrand factor-cleaving protease in chronic relapsing thrombotic thrombocytopenic purpura [J].
Furlan, M ;
Robles, R ;
Solenthaler, M ;
Wassmer, M ;
Sandoz, P ;
Lammle, B .
BLOOD, 1997, 89 (09) :3097-3103